Publications

TSC Real Estate ramps up investments in European healthcare, life sciences sectors
Investors - NOVEMBER 14, 2022

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

TSC Real Estate ramps up investments in European healthcare, life sciences sectors

by Kali Persall

TSC Real Estate, a longstanding specialist in healthcare real estate, has unveiled plans to roll out a new investment vehicle to take advantage of the opportunities in the European healthcare and life sciences sectors.

Among the global drivers of the healthcare and science infrastructure sector are the systematic demand for healthcare due to the aging global population, and the questions of how to prepare for future pandemics and how to feed some 10 billion people in the year 2050, according to TSC Real Estate.

Capital investments in the healthcare and life sciences sectors have increased in recent years. In 2021, the entire global capital investment volume — including M&A, IPOs, venture capital and private equity — increased by about 43 percent year-over-year to about €803 billion ($831 billion). The actual volume of venture-capital financing in biotech and pharmaceutical start-ups increased by 41 percent year-over-year to a total of €5 billion ($5.17 bill

Forgot your username or password?